Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kezar Life Sciences (KZR) FCF Margin (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed FCF Margin for 5 consecutive years, with 4236.75% as the latest value for Q2 2025.

  • Quarterly FCF Margin fell 1038.0% to 4236.75% in Q2 2025 from the year-ago period, while the trailing twelve-month figure was 7979.2% through Dec 2025, down 128934.0% year-over-year, with the annual reading at 1192.21% for FY2023, N/A changed from the prior year.
  • FCF Margin hit 4236.75% in Q2 2025 for Kezar Life Sciences, down from 4956.2% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 7215.72% in Q4 2021 to a low of 290.59% in Q3 2023.
  • Historically, FCF Margin has averaged 4813.62% across 5 years, with a median of 5179.87% in 2022.
  • Biggest five-year swings in FCF Margin: surged 72962bps in 2023 and later plummeted -147728bps in 2024.
  • Year by year, FCF Margin stood at 7215.72% in 2021, then fell by -29bps to 5118.01% in 2022, then tumbled by -106bps to 290.59% in 2023, then soared by 1562bps to 4247.13% in 2024, then decreased by 0bps to 4236.75% in 2025.
  • Business Quant data shows FCF Margin for KZR at 4236.75% in Q2 2025, 4956.2% in Q1 2025, and 4247.13% in Q2 2024.